Cargando…

Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study

BACKGROUND AND AIM OF THE STUDY: Rheumatic mitral stenosis (RMS) is an autoimmune, progressive destructive valve disease occurring as a sequele of streptococcal infection. Epidemiological studies support an association of vitamin D deficiency with initial susceptibility and severity of autoimmune di...

Descripción completa

Detalles Bibliográficos
Autores principales: Yusuf, Jamal, P, Jothinath, Mukhopadhyay, Saibal, Vignesh, Vickram, Tyagi, Sanjay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993921/
https://www.ncbi.nlm.nih.gov/pubmed/29716696
http://dx.doi.org/10.1016/j.ihj.2017.06.010
_version_ 1783330318487388160
author Yusuf, Jamal
P, Jothinath
Mukhopadhyay, Saibal
Vignesh, Vickram
Tyagi, Sanjay
author_facet Yusuf, Jamal
P, Jothinath
Mukhopadhyay, Saibal
Vignesh, Vickram
Tyagi, Sanjay
author_sort Yusuf, Jamal
collection PubMed
description BACKGROUND AND AIM OF THE STUDY: Rheumatic mitral stenosis (RMS) is an autoimmune, progressive destructive valve disease occurring as a sequele of streptococcal infection. Epidemiological studies support an association of vitamin D deficiency with initial susceptibility and severity of autoimmune diseases. The aim of the present study was to assess serum level of 25 hydroxyvitamin D in subjects of RMS and assess if any correlation exists with serum levels of vitamin D and severity of disease along with calcification assessed semi-quantitatively by echocardiography by applying Wilkins score. METHOD: Fifty five patients of RMS without any calcification of the valves (Group A) assessed by echocardiography along with fifty five patients of RMS with mild to moderately calcified valves (Group B, Wilkins calcium score 1 or 2) and 55 patients with severely calcified valves (Group C, Wilkins calcium score 3 or 4) were enrolled for the study. All subjects underwent clinical, echocardiographic, and biochemical evaluation. The total Wilkins score, Wilkins calcium score along with serum level of 25 hydroxyvitamin D was evaluated in all the patients. RESULTS: The median serum level of 25 hydroxyvitamin D was significantly lower in Group B (20.4 ng/ml, p < 0.001) and group C (11.4 ng/ml, p < 0.001) compared to Group A patients (27.9 ng/ml). Similarly serum level of 25 hydroxyvitamin D in Group C patients were significantly less than Group B patients (p < 0.001). A significant inverse correlation was identified between serum level of 25 hydroxyvitamin D and total Wilkins score (r = −0.65, p < 0.001) as well as Wilkins calcium score (r = −0.69, p < 0.001). But no correlation was identified between 25 hydroxyvitamin D levels and other echocardiographic parameters of RMS. CONCLUSION: Our study showed a significantly lower level of 25 hydroxyvitamin D in subjects of RMS with severely damaged and calcified valves as compared to those with less severely damaged non-calcified valves and it correlated with both Wilkins score and Wilkins calcification score. Thus a link may exist between vitamin D deficiency (an immunomodulator) and severity of autoimmune injury on the valves.
format Online
Article
Text
id pubmed-5993921
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-59939212019-03-01 Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study Yusuf, Jamal P, Jothinath Mukhopadhyay, Saibal Vignesh, Vickram Tyagi, Sanjay Indian Heart J Clinical and Preventive Cardiology BACKGROUND AND AIM OF THE STUDY: Rheumatic mitral stenosis (RMS) is an autoimmune, progressive destructive valve disease occurring as a sequele of streptococcal infection. Epidemiological studies support an association of vitamin D deficiency with initial susceptibility and severity of autoimmune diseases. The aim of the present study was to assess serum level of 25 hydroxyvitamin D in subjects of RMS and assess if any correlation exists with serum levels of vitamin D and severity of disease along with calcification assessed semi-quantitatively by echocardiography by applying Wilkins score. METHOD: Fifty five patients of RMS without any calcification of the valves (Group A) assessed by echocardiography along with fifty five patients of RMS with mild to moderately calcified valves (Group B, Wilkins calcium score 1 or 2) and 55 patients with severely calcified valves (Group C, Wilkins calcium score 3 or 4) were enrolled for the study. All subjects underwent clinical, echocardiographic, and biochemical evaluation. The total Wilkins score, Wilkins calcium score along with serum level of 25 hydroxyvitamin D was evaluated in all the patients. RESULTS: The median serum level of 25 hydroxyvitamin D was significantly lower in Group B (20.4 ng/ml, p < 0.001) and group C (11.4 ng/ml, p < 0.001) compared to Group A patients (27.9 ng/ml). Similarly serum level of 25 hydroxyvitamin D in Group C patients were significantly less than Group B patients (p < 0.001). A significant inverse correlation was identified between serum level of 25 hydroxyvitamin D and total Wilkins score (r = −0.65, p < 0.001) as well as Wilkins calcium score (r = −0.69, p < 0.001). But no correlation was identified between 25 hydroxyvitamin D levels and other echocardiographic parameters of RMS. CONCLUSION: Our study showed a significantly lower level of 25 hydroxyvitamin D in subjects of RMS with severely damaged and calcified valves as compared to those with less severely damaged non-calcified valves and it correlated with both Wilkins score and Wilkins calcification score. Thus a link may exist between vitamin D deficiency (an immunomodulator) and severity of autoimmune injury on the valves. Elsevier 2018 2017-06-17 /pmc/articles/PMC5993921/ /pubmed/29716696 http://dx.doi.org/10.1016/j.ihj.2017.06.010 Text en © 2017 Published by Elsevier B.V. on behalf of Cardiological Society of India. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Clinical and Preventive Cardiology
Yusuf, Jamal
P, Jothinath
Mukhopadhyay, Saibal
Vignesh, Vickram
Tyagi, Sanjay
Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title_full Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title_fullStr Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title_full_unstemmed Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title_short Evaluation of serum 25-hydroxyvitamin D levels in calcific rheumatic mitral stenosis— A cross sectional study
title_sort evaluation of serum 25-hydroxyvitamin d levels in calcific rheumatic mitral stenosis— a cross sectional study
topic Clinical and Preventive Cardiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993921/
https://www.ncbi.nlm.nih.gov/pubmed/29716696
http://dx.doi.org/10.1016/j.ihj.2017.06.010
work_keys_str_mv AT yusufjamal evaluationofserum25hydroxyvitamindlevelsincalcificrheumaticmitralstenosisacrosssectionalstudy
AT pjothinath evaluationofserum25hydroxyvitamindlevelsincalcificrheumaticmitralstenosisacrosssectionalstudy
AT mukhopadhyaysaibal evaluationofserum25hydroxyvitamindlevelsincalcificrheumaticmitralstenosisacrosssectionalstudy
AT vigneshvickram evaluationofserum25hydroxyvitamindlevelsincalcificrheumaticmitralstenosisacrosssectionalstudy
AT tyagisanjay evaluationofserum25hydroxyvitamindlevelsincalcificrheumaticmitralstenosisacrosssectionalstudy